Watchlist Price Alert

Dermata Therapeutics Inc. (DRMA)

NASDAQ: DRMA · Real-Time Price · USD

0.73

-0.00 (-0.54%)

At close: Jun 13, 2025, 11:32 AM

Dermata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-12.29M	-7.79M	-9.61M	-7.9M	-3.24M	-4.72M
Depreciation & Amortization	n/a	n/a	n/a	14.13K	322.00	1.35K
Stock-Based Compensation	657.65K	522.08K	930.33K	1.91M	n/a	730.96
Other Working Capital	575.38K	494.35K	-135.03K	-121.42K	-522.94K	-197.41K
Other Non-Cash Items	n/a	369.33K	930.33K	14.13K	-36.49K	872.72K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-730.96
Change in Working Capital	466.86K	494.35K	-153.58K	289.55K	-755.85K	-74.99K
Operating Cash Flow	-11.16M	-6.41M	-8.83M	-5.69M	-4.03M	-3.92M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	1.01M	2.3M	-626.17K
Common Stock Repurchased	-828	-40	n/a	-1M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.11K	187.00	287.00	n/a	2.97M	n/a
Financial Cash Flow	6.89M	7.61M	4.28M	15.96M	2.57M	4.73M
Net Cash Flow	-4.28M	1.2M	-4.56M	10.27M	-1.46M	812.19K
Free Cash Flow	-11.16M	-6.41M	-8.83M	-5.69M	-4.03M	-3.92M